blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2383286

EP2383286 - Methods and compositions for treatment of retinal degenerative diseases [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  24.02.2012
Database last updated on 30.09.2024
Most recent event   Tooltip24.02.2012Refusal of applicationpublished on 28.03.2012  [2012/13]
Applicant(s)For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75013 Paris / FR
[2011/44]
Representative(s)Hirsch, Denise Marie
Inserm-Transfert Industrial Property Department Biopark 7 rue Watt
75013 Paris / FR
[2011/44]
Application number, filing date10305464.930.04.2010
[2011/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2383286
Date:02.11.2011
Language:EN
[2011/44]
Search report(s)(Supplementary) European search report - dispatched on:EP16.08.2010
ClassificationIPC:C07K14/215, C07K14/47, A61K38/16, A61K38/17
[2011/44]
CPC:
C07K14/215 (EP); C07K14/47 (EP); A61K38/00 (EP);
Y02A50/30 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/44]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:Verfahren und Zusammensetzungen zur Behandlung von degenerativen Netzhauterkrankungen[2011/44]
English:Methods and compositions for treatment of retinal degenerative diseases[2011/44]
French:Procédés et compositions pour le traitement des maladies rétiniennes dégénératives[2011/44]
Examination procedure10.11.2011Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2012/13]
11.11.2011Application refused, date of legal effect [2012/13]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2009127705  (NOVARTIS FORSCHUNGSSTIFTUNG [CH], et al) [Y] 1-12 * claims 1,2 *;
 [Y]WO2009146183  (GENZYME CORP [US], et al) [Y] 1-12 * claims 1-4 *;
 [Y]WO2008148860  (INST NAT SANTE RECH MED [FR], et al) [Y] 1-12 * claims 1-12 *;
 [Y]WO02081513  (NOVARTIS AG [CH], et al) [Y] 1-12 * claims 1,23-28 *
 [Y]  - GRADINARU V ET AL, "eNpHR: A Natronomonas halorhodopsin enhanced for optogenetic applications", BRAIN CELL BIOLOGY ; A JOURNAL OF CELLULAR NEUROBIOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE LNKD- DOI:10.1007/S11068-008-9027-6, vol. 36, no. 1-4, ISSN 1559-7113, (20080801), pages 129 - 139, (20080802), XP002557433 [Y] 1-12 * abstract * * page 130, column l, line 3 - column r, paragraph 1 * * page 133, column r, paragraph 2 - page 135, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1007/s11068-008-9027-6
by applicantWO2009127705
 WO02081513
 WO2008148860
 WO9424983
 WO9011092
 US5185152
 US5710182
 US5443505
 US4853224
 US4997652
 US5554187
 US4863457
 US5098443
 US5725493
 US5378475
    - GRADINARU, V.; THOMPSON, K. R.; DEISSEROTH, K., "eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications", BRAIN CELL BIOL, (2008), vol. 36, pages 129 - 39
    - WU Z; ASOKAN A; SAMULSKI RJ, "Adeno-associated virus serotypes: vector toolkit for human gene therapy", MOL THER, (2006), vol. 14, pages 316 - 327
    - CHOI VW; SAMULSKI RJ; MCCARTY DM, "Effects of adeno-associated virus DNA hairpin structure on recombination", J VIROL, (2005), vol. 79, pages 6801 - 6807
    - DINCULESCU ET AL., HUM GENE THER., (200506), vol. 16, no. 6, pages 649 - 63
    - LEBHERZ, C.; MAGUIRE, A.; TANG, W.; BENNETT, J.; WILSON, J. M., "Novel AAV serotypes for improved ocular gene transfer", J GENE MED, (2008), vol. 10, pages 375 - 82
    - PROC NATL ACAD SCI, (1993), vol. 84, pages 7413 - 7417
    - HUMAN GENE THERAPY, (1992), vol. 3, pages 147 - 154
    - PROC NATL ACAD SCI, (1990), vol. 87, pages 3410 - 3414
    - GENE THER., (20080313), vol. 15, no. 14, pages 1049 - 55
    - KOMAROMY AM; ALEXANDER JJ; COOPER AE; CHIODO VA; GLUSHAKOVA LG; ACLAND GM; HAUSWIRTH WW; AGUIRRE GD, "three photoreceptor specifc promoters (interphotoreceptor retinoid binding protein-IRPB 1783; guanylate cyclase activating protein 1-GCAP292; rhodopsin-mOP500)", MOL VIS., (20071018), vol. 13, pages 2001 - 11
    - SEMPLE-ROWLAND SL; ECCLES KS; HUMBERSTONE EJ, "the human rhodopsin kinase (RK) promoter", INVEST OPHTHALMOL VIS SCI., (200709), vol. 48, no. 9, pages 3954 - 61
    - KHANI SC; PAWLYK BS; BULGAKOV OV; KASPEREK E; YOUNG JE; ADAMIAN M; SUN X; SMITH AJ; ALI RR; LI T., "the promoter for the alpha subunit of cone transducin or the cone photoreceptor regulatory element 1 (CPRE-1) a novel 20-bp enhancer element in the TalphaC promoter", J BIOL CHEM., (20080418), vol. 283, no. 16, pages 10881 - 91
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.